Locally-directed radiotherapy has been reported by Victorian clinicians to boost the effect of systemic PD-1 inhibition in refractory classical Hodgkin lymphoma. A case study of a 24-year-old male with disease progression despite multiple therapies including nivolumab, appears to show an abscopal effect from radiation therapy to infradiaphragmatic sites. “Repeat PET/CT 6 weeks postradiotherapy demonstrated complete ...
Synergistic response with radiotherapy and immune therapy in Hodgkin lymphoma
By Mardi Chapman
28 Mar 2018